Related Experiment Video
Updated: Aug 9, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Case report: Early-onset parkinsonism among the neurological features in children with PHACTR1 variants
Roberto Previtali1, Alessia Leidi1, Martina Basso1
1University of Milan, Milan, Italy.
Insights
Pathogenic variants in PHACTR1 gene are linked to early-onset epilepsy and intellectual disability. New cases reveal potential new neurological symptoms like speech and movement disorders in PHACTR1-mutated patients.
Area of Science:
- Genetics and Neurology
- Molecular Biology
Background:
- The PHACTR1 gene is expressed in cardiovascular and neurological tissues, playing a role in brain maturation.
- Previously identified PHACTR1 mutations in patients were associated with early-onset epilepsy and intellectual disability.
Observation:
- Two new cases of de novo pathogenic variants in PHACTR1 were identified, presenting with early-onset developmental and epileptic encephalopathy.
- One patient exhibited a progressive movement disorder (hypertonus, hypo-bradykinesia, hypomimia, ataxic gait, retropulsion) and a speech disorder, unresponsive to levodopa treatment.
Findings:
- PHACTR1 variants can manifest with either cardiological or neurological phenotypes.
- Severe developmental delay, intellectual disability, and early-onset epileptic encephalopathy are characteristic neurological features.
- The newly observed movement and speech disorders may represent novel aspects of the PHACTR1-related neurological phenotype.
Implications:
- Expanding the understanding of the PHACTR1 gene's role in neurological development and disease.
- Highlighting the potential for PHACTR1 mutations to cause a broader spectrum of neurological symptoms than previously recognized.
- Informing future diagnostic and therapeutic strategies for patients with PHACTR1-associated disorders.
Abstract:
PACHTR1 is expressed in cardiovascular and neurological tissues. In the brain, it has a role in pre- and post-natal maturation. Previously reported PHACTR1-mutated patients showed early-onset epilepsy and intellectual disability. We describe two unreported cases with de novo pathogenic variants in PHACTR1 and their clinical pictures, compared with those of cases already reported in the literature. In line with previous reports, the two patients presented early-onset developmental and epileptic encephalopathy. In addition, one patient developed a speech disorder and a progressive movement disorder characterized by hypertonus, hypo-bradykinesia, hypomimia, ataxic gait, and retropulsion. She was treated with levodopa without any clinical improvement. Pathogenic variants in PHACTR1 may result in a cardiological or neurological phenotype. Severe developmental delay, intellectual disability, and early-onset developmental and epileptic encephalopathy are the main features of PHACTR1-mutated patients with neurological involvement. Movement and speech disorders have never previously been described and could be new features of the neurological phenotype.
Related Concept Videos
Neural Regulation
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Huntington Disease l: Introduction
Alterations in Muscle Tone lll

